[Amlexanox has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA)]. 1993

S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
Second Department of Internal Medicine, Hamamatsu University School of Medicine, Japan.

Recently, we have reported that a nebulized solution of sodium cromoglycate (SCG) (Intal), a well known antiallergic agent, has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA). Amlexanox is an antiallergic agent, with a structure similar to that of SCG. Therefore, we investigated the acute bronchodilator effect of amlexanox administered orally to adult asthmatics, focusing on a comparison between AIA and non-AIA patients. Fifteen patients participated, 8 having AIA and 7 non-AIA. After performing spirometry during remission, they were administered either amlexanox or placebo using a randomized double-blind protocol. Spirometry was then performed at 30, 60, 90 min, 2 h, and 3 h after administration. The placebo used was lactose. In the AIA group, FEV1 was significantly improved after administration of amlexanox. However, FEV1 was significantly decreased after placebo administration. On the other hand, in the non-AIA group, FEV1 was not changed after administration of either of the drugs. From these results, we conclude that amlexanox has an acute bronchodilator effect only in AIA patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000631 Aminopyridines Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond. Aminopyridine

Related Publications

S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
October 1992, Arerugi = [Allergy],
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
May 2005, Nihon rinsho. Japanese journal of clinical medicine,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
January 2006, European annals of allergy and clinical immunology,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
March 1997, Allergy,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
July 2002, Thorax,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
July 2002, Allergy,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
June 1992, Nihon Kyobu Shikkan Gakkai zasshi,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
January 1993, Journal of investigational allergology & clinical immunology,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
February 2010, MMW Fortschritte der Medizin,
S Imokawa, and A Satou, and M Taniguchi, and M Toyoshima, and K Nakazawa, and H Hayakawa, and K Chida
January 1988, Problemy tuberkuleza,
Copied contents to your clipboard!